Robin goodfellow.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D000068579:Celecoxib; D002986:Clinical Trials as Topic; D006801:Humans; D000069285:Infliximab; D010003:Osteoarthritis; D011720:Pyrazoles; D012216:Rheumatic Diseases / Q000188:drug therapy; D012219:Rheumatology / Q000639:trends*; D013449:Sulfonamides / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D011720:Pyrazoles; D013449:Sulfonamides; D000069285:Infliximab; D000068579:Celecoxib